Pharmaceutical Overview
Loette 0.1/0.02 mg Wyeth Ltd. is a combination oral contraceptive tablet containing ethinylestradiol and levonorgestrel, manufactured by Wyeth Pharmaceuticals. This pharmaceutical preparation represents a low-dose hormonal combination formulation widely studied in reproductive endocrinology research. Each tablet contains 0.02 mg ethinylestradiol and 0.1 mg levonorgestrel, providing researchers with standardised hormone concentrations for investigation into estrogen-progestin interactions and reproductive hormone modulation pathways. The compound serves as a valuable reference standard for researchers at Stroid UK Shop studying synthetic hormone pharmacokinetics and receptor binding affinities.
Laboratory Research Applications
Research teams investigating reproductive hormone mechanisms utilise Loette tablets to examine estrogen-progestin synergy in cell culture models and molecular studies. The ethinylestradiol component provides researchers with a synthetic estrogen analogue for studying estrogen receptor activation patterns, while the levonorgestrel offers insights into third-generation progestin receptor interactions. Scientists analyse these compounds alongside other pharmaceutical research tools to evaluate hormone-dependent cellular responses and transcriptional regulation. Academic laboratories examine the bioavailability characteristics and metabolic pathways of combination hormonal preparations. Comparative studies with selective androgen receptor modulators help researchers understand tissue-specific hormonal mechanisms. Additionally, investigations into hormone-mediated gene expression often incorporate these standardised pharmaceutical preparations alongside peptide research compounds for comprehensive endocrine system analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredients | Ethinylestradiol 0.02 mg, Levonorgestrel 0.1 mg |
| Manufacturer | Wyeth Ltd. |
| Formulation | Oral tablets |
| CAS Numbers | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | Reproductive endocrinology, hormone receptor studies |
| Purity | Pharmaceutical grade |
Research Compliance Statement
Loette 0.1/0.02 mg Wyeth Ltd. tablets are supplied exclusively for in-vitro laboratory research and analytical studies. These pharmaceutical preparations are not intended for human consumption, clinical application, or therapeutic use. Researchers must handle all materials according to institutional biosafety protocols and maintain appropriate storage conditions. All studies involving these compounds should comply with relevant research guidelines and regulatory frameworks governing pharmaceutical research materials.
